Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer

Int J Gynaecol Obstet. 2013 Apr;121(1):53-5. doi: 10.1016/j.ijgo.2012.10.027. Epub 2013 Jan 23.

Abstract

Objective: To report the clinical outcomes of patients with FIGO stage IC epithelial ovarian cancer (EOC) treated by fertility-sparing surgery (FSS).

Methods: A retrospective review was conducted of 18 women who underwent FSS at Niigata University Hospital, Japan, between December 15, 1986, and December 31, 2010.

Results: Tumors were mucinous (n=9), clear cell (n=4), endometrioid (n=3), and serous (n=2). Median follow-up was 78.0 months (range, 9.3-181.3 months). Five patients (27.8%) developed tumor recurrence at 7.4-19.2 months after initial surgery. The sites of recurrence were peritoneal lymph nodes (n=2), contralateral ovary (n=1), contralateral ovary and peritoneal cavity (n=1), and brain (n=1). In all, 7 full-term singleton pregnancies were recorded among 5 of the 10 women who attempted to conceive after FSS.

Conclusion: Favorable reproductive outcomes were observed following FSS, suggesting that this procedure may be a valid treatment option for women with FIGO stage IC EOC who wish to conceive.

MeSH terms

  • Adolescent
  • Adult
  • Carcinoma, Ovarian Epithelial
  • Female
  • Fertility Preservation / methods*
  • Follow-Up Studies
  • Hospitals, University
  • Humans
  • Japan
  • Lymphatic Metastasis
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Neoplasms, Glandular and Epithelial / pathology
  • Neoplasms, Glandular and Epithelial / surgery*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery*
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Rate*
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Young Adult